Skip to main content
Clinical Trials/NCT05637125
NCT05637125
Completed
Not Applicable

Effect of Different Types of Aerobic Training on Peak VO2 and Ejection Fraction for Diastolic Heart Failure Patients; a Comparative Randomized Control Trial

Beni-Suef University1 site in 1 country40 target enrollmentAugust 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Effect of Different Types of Aerobic Training on Diastolic Heart Failure Patients
Sponsor
Beni-Suef University
Enrollment
40
Locations
1
Primary Endpoint
Ejection fraction
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Background: Heart failure is described by a lack of confirmed efficient therapies and exercise intolerance. Physical activity is related to a lower risk of adverse cardiovascular consequences, involving heart failure. The purpose of the study: determine the effect of different types of aerobic training on peak VO2 and ejection fraction in diastolic heart failure patients. Subject and methods: Forty eligible male patients with diastolic heart failure, aged between 50 - 60 years old, participated in this study. They were selected from an outpatient clinic of general Zagazig hospital and were assigned into 2 equal groups in numbers. The first group (A) received aerobic exercise for the upper limb in form of arm ergometer exercises, while the second group (B) received aerobic exercise for the lower limb in form of cycling. Training duration for both groups was 3 sessions/week for 12 weeks. Peak VO2, and ejection fraction of both groups were measured and compared pre and post-treatment. Results: There was no significant difference in the ejection fraction between groups post-treatment. There was a significant increase in the peak VO2 of group B compared with that of group A post-treatment. Conclusion: there is no effect of different types of aerobic training on ejection fraction and peak VO2 for diastolic heart failure patients, but lower limb exercise is more effective than upper limb exercise in improvement of peak VO2 for diastolic heart failure patients.

Detailed Description

Ejection fraction and peak VO2 of both groups were measured pre exercise program and after 12 weeks at the end of the study exercise program. * Vivid S5 cardiovascular ultrasound system (BT308), made in china, was used to measure ejection fraction. * Oxycon pro (ER900, Germany) cardiopulmonary exercise test unit was used to measure Peak Vo2 Treatment procedure: Group A received aerobic exercise for upper limb in the form of arm ergometer 3 session/week for 12 weeks. Patient started with warming up for 5 minutes in form of stretching. Patients used arm ergometer without resistance for upper limb aerobic exercise for 20 minutes and instructed to take rest if they feel tired or fatigue. The intensity was according to rate of perceive exertion, after 20 minutes, patients were asked to cool down for 5 minutes in the form of stretching at the end of an exercise session. Group B received aerobic exercise for lower limb in the form of cycling 3session/week for 12 weeks. Patient started with warming up for 5 minutes. Patients used bicycle for lower limb aerobic exercise for 20 minutes and instructed to take rest if they feel tired or fatigue. The intensity was according to rate of perceive exertion. After 20 minutes, patients were asked to cool down for 5 minutes in the form of stretching at the end of an exercise session.

Registry
clinicaltrials.gov
Start Date
August 1, 2021
End Date
January 1, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Tamer Ibrahim Abo Elyazed

Ass.prof

Beni-Suef University

Eligibility Criteria

Inclusion Criteria

  • male gender
  • under complete medical supervision
  • left ventricular end diastolic dimension \>5.5cm
  • ejection fraction \<50%.

Exclusion Criteria

  • Orthopedic problems
  • Mental disorders
  • Metabolic disorders (D.M)
  • Current treatment for cancer or active infection.

Outcomes

Primary Outcomes

Ejection fraction

Time Frame: 12 weeks

Vivid S5 cardiovascular ultrasound system (BT308), made in china, was used to measure ejection fraction.

peak VO2

Time Frame: 12 weeks

Oxycon pro (ER900, Germany) cardiopulmonary exercise test unit was used to measure Peak Vo2

Study Sites (1)

Loading locations...

Similar Trials